Suppressive effect of tetraprenylacetone on gastric atrophy induced by short-term administration of N-methyl-N'-nitro-N-nitrosoguanidine in rats

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 3, 1997, Pages 613-618

  Miwa, H ^a   Nagahara, A ^a   Wada, R ^a   Hirai, S ^a   Endo, K ^a   Watanabe, S ^a   Sato, N ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; METHYLNITRONITROSOGUANIDINE; TEPRENONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHY; CARCINOGENICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; RAT; STOMACH CARCINOMA; STOMACH MUCOSA LESION;

EID: 0030751842     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00162.x     Document Type: Article

References (25)

1. Sugimura T, Fujimura S. Tumor production in glandular stomach of rat by N-methyl-N′-nitro-N-nitrosoguanidine. Nature 1967; 216: 943-4.
2. Saito T, Inokuchi K, Takayama S, Sugimura T. Sequential morphological changes in N-methyl-N′-nitro-N-nitrosoguanidine carcinogenesis in the glandular stomach of rats. J Natl Cancer Inst 1970; 44: 769-83.
3. Kobori O, Gedigk P, Totovic V. Early changes of glandular stomach in Wistar rats ingesting N-methyl-N′-nitro-N-nitrosoguanidine (MNNG): With special reference to light microscopic, electron microscopic, and enzyme histochemical study of the regenerating epithelium induced by MNNG. Z Krebsforsch 1976; 87: 127-38.
4. Tatemetsu M, Takahashi M, Fukushima S, Hananouchi M, Shirai T. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N′-nitro-N-nitrosoguanidine or 4-nitroquinoline 1 oxide. J Natl Cancer Inst 1975; 55: 101-6.
5. Fukushima S, Tatematsu M, Takahashi M. Combined effect of various surfactants on gastric carcinogenesis in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Gann 1974; 65: 571-6.
6. Matsukura N, Kawachi T, Sano T, Sasajima K, Sugimura T. Promoting action of croton oil on gastrocarcinogenesis by N-methyl-N′-nitro-N-nitrosoguanidine. J Cancer Res Clin Oncol 1979; 95: 525-7.
7. Takahashi M, Shirai T, Fukushima S, Hananouchi M, Hirose M, Ito N. Effect of fundic ulcers induced by indoacetamide on development of gastric tumors in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Gann 1976; 67: 47-54.
8. Fukushima S, Hamanouchi M, Shirai T, et al. Effect of plastic bead on gastric carcinogenesis in rats treated with N-methyl-N′-nitro-N-nilrosoguanidine. Gann 1976; 67: 197-201.
9. Tatematsu M, Takahashi M, Hamanouchi M, et al. Protective effect of mucinon experimental gastric cancer induced by N-methyl-N′-nitro-N-nitrosoguanidine plus sodium chloride in rats. Gann 1976; 67: 223-9.
10. Murakami M, Oketani K, Fujisaki H, Wakabayashi T, Ohgo T. Antiulcer effect of Geranylgeranylacetone, a new acyclic polyisoprenoid, on experimentally induced gastric and duodenal ulcer in rats. Arzneim-Forsch 1981; 31 (5): 799-801.
11. Bilski J, Murty VLN, Nadziejko C, et al. Protection against alcohol-induced gastric mucusal injury by Geranylgeranylacetone; Effect of indomethacin. Digestion 1988; 41: 22-35.
12. Terano A, Shiga J, Hiraishi H, Ota S, Sugimoto T. Protective action of Tetraprenylacetone against ethanol-induced damage in rat gastric mucosa. Digestion 1986; 35: 182-8.
13. Murakami M, Oketani K, Fujisaki H, Wakabayashi T. Effect of Geranylgeranylacetone (GGA) on gastric lesions induced by topical aspirin plus HCI. Jpn J Pharmacol 1982; 32: 921-4.
14. Aono M, Moriga M, Mizuta K, Uchino H. Effect of tetraprenylacetone on the content of phospholiplds in gastric secretions in man. Gastroenterol Jpn 1986; 21 (5): 454-8.
15. Kunisaki C, Sugiyama M. Effect of Tetraprenylacetone on acute gastric mucosal lesions induced by cold-restraint stress. Digestion 1992; 53: 45-53.
16. Murata T, Wada R, Abe H, Kuwabara N, Fukuda Y. Studies of morphometric analysis and cell cycle of gastric epithelia of rats administrated minimal mixed bile acids. Jpn J Gastroenterol 1991; 88 (8): 1532-8.
17. Gratzner H. Monoclonal antibody to 5-bromo and 5-iodo-deoxyuridine: A new reagent for detection of DNA replication. Science 1982; 218: 474-5.
18. Biasco G, Paganelli GM, Santucci R, Miglioli M, Barbara L. Cell proliferation kinetics as a marker of gastric cancer risk. Ital J Gastroenterol 1991; 23: 24-8.
19. Lipkin M, Correa P, Mikol YB, et al. Proliferative and antigenic modification in human epithelial cells in chronic atrophic gastritis. J Nat Cancer Inst 1985; 75: 613-9.
20. Deschner EE, Tamura K, Bralow SP. Early proliferative change in rats pyloric mucosa induced with N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). Front Gastrointest Res 1979; 4: 25-31.
21. Quimby GF, Eastwood GL. Effect of N-methyl-N′-nitro-N-nitrosoguanidine on gastroduodenal epithelial proliferation in Wistar/Lewis rats. J Natl Cancer Inst 1981; 66 (2): 331-7.
22. Terano A, Hiraishi H, Ota S, Sugimoto T. Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 1986; 33: 206-10.
23. Nagahara A, Watanabe S, Miwa H, Endo K, Hirose M, Sato N. Reduction of gap junction protein connexin 32 in rat atrophic mucosa as an early event in carcinogenesis. J Gastroenterol 1996; 31: 491-7.
24. Bilski J, Sarosiek J, Murty VL, et al. Enhancement of the lopid content and physical properties of gastric mucus by geranylgeranylacetone. Biochem Pharmacol 1987; 36: 4059-65.
25. Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induced heal shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996; 111: 345-57.